Header cover image

Pharmaceuticals & Biotech Consumer Discretionary

Results

1272

0 new

All the companies in the consumer discretionary sector including household durables, leisure products and luxury goods.

1,272 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

MGTX

MeiraGTx Holdings		US$4.264.9%-8.4%US$329.7mUS$20.60PS40.6xE7.8%n/a

ESPR

Esperion Therapeutics		US$1.683.1%73.2%US$329.7mUS$7.59PS1.2xE64.2%n/a

ALDX

Aldeyra Therapeutics		US$5.50-1.4%-9.2%US$326.8mUS$10.00PB3.3xE62.3%n/a

ANRO

Alto Neuroscience		US$12.10-9.0%n/aUS$326.2mUS$31.20PB1.8xE-23.4%n/a

INZY

Inozyme Pharma		US$5.18-1.3%32.1%US$325.0mUS$19.00PB3.4xE0.5%n/a

CRVS

Corvus Pharmaceuticals		US$5.15-5.3%265.2%US$322.1mUS$10.13PB6.3xE-3.9%n/a

KRRO

Korro Bio		US$34.51-0.5%n/aUS$320.9mUS$132.20PB1.6xE-10.4%n/a

VYGR

Voyager Therapeutics		US$5.85-4.1%-19.2%US$319.0mUS$17.63PE35.4xE-24.1%n/a

NKTX

Nkarta		US$4.52-7.0%245.0%US$318.9mUS$17.33PB0.7xE-11.1%n/a

NIKA

Nika Pharmaceuticals		US$0.310%n/aUS$317.9mn/aPS2037626.6xn/an/a

GLUE

Monte Rosa Therapeutics		US$5.17-13.1%14.4%US$317.3mUS$14.57PS55.1xE26.1%n/a

XOMA

XOMA Royalty		US$26.00-4.0%85.4%US$304.3mUS$83.00PS20xE74.3%n/a

OYST

Oyster Point Pharma		US$11.170%-29.7%US$303.2mUS$25.25PS15.5xE59.5%n/a

HRTX

Heron Therapeutics		US$1.990.5%102.8%US$301.8mUS$6.75PS2.2xE69.2%n/a

DSGN

Design Therapeutics		US$5.33-0.4%133.8%US$301.8mUS$7.00PB1.2xE-15.3%n/a

LXEO

Lexeo Therapeutics		US$9.11-3.5%n/aUS$301.2mUS$22.43PB1.8xE-4.4%n/a

ADCT

ADC Therapeutics		US$3.080%273.7%US$297.8mUS$10.25PS4.5xE26.7%n/a

PSNL

Personalis		US$5.223.1%314.3%US$296.0mUS$7.08PS3.7xE32.5%n/a

OCGN

Ocugen		US$1.02-1.9%154.7%US$293.6mUS$7.00PS40.4xE36.2%n/a

AVIR

Atea Pharmaceuticals		US$3.44-0.3%14.7%US$290.4mUS$7.12PB0.6xE-4.8%n/a

ATLN

Atlantic International		US$5.95-2.0%n/aUS$289.9mn/aPB12.6xn/an/a

CDXC

ChromaDex		US$3.801.6%160.3%US$289.2mUS$6.54PS3.4xE102.9%n/a

RIGL

Rigel Pharmaceuticals		US$16.4220.2%59.4%US$288.9mUS$26.75PS2.2xE57.8%n/a

PEPG

PepGen		US$8.82-1.8%90.1%US$287.4mUS$19.60PB1.9xE14.9%n/a
Page 15 of 53
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.